Malin Corporation | MLC - Market Capitalization

Stock Price
7.60
Daily Change
0 0%
Monthly
0%
Yearly
-24.00%
Q1 Forecast
7.37

Malin Corporation reported EUR142.92M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
ALKERMES USD 4.62B 333M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Eurofins Scientific SE EUR 11.01B 1.49B Jun/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025